Opendata, web and dolomites

MAPSYNE SIGNED

Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MAPSYNE project word cloud

Explore the words cloud of the MAPSYNE project. It provides you a very rough idea of what is the project "MAPSYNE" about.

cell    arrays    cns    neuronal    ec    network    disease    preclinical    aps    single    track    health    amyotrophic    neurodegenerative    mapping    als    worldwide    primary    human    microelectrode    brain    detection    functional    stem    people    more    er    synaptic    drug    hardware    patching    temporal    neurons    technologies    clinical    networks    signals    dysfunction    label    automated    thousands    aging    record    density    clamp    cells    proof    cultures    lateral    central    spatial    societies    https    discovery    commercialization    mini    failures    propagating    europa    suffer    hd    miniaturized    patch    scales    nervous    pluripotent    compartments    blockers    local    alzheimer    mapsyne    million    meas    cure    designed    165    model    action    drugs    combined    screening    potentials    trials    repeated    free    demand    sclerosis    software    events    electrical    assays    recording    billion    axons    diseases    envisions    phases    combining    experiments    parallel    parkinson    ipsc    vitro    healthcare   

Project "MAPSYNE" data sheet

The following table provides information about the project.

Coordinator
MAXWELL BIOSYSTEMS AG 

Organization address
address: ALBISRIEDERSTRASSE 253
city: ZURICH
postcode: 8047
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 187˙419 €
 EC max contribution 187˙419 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAXWELL BIOSYSTEMS AG CH (ZURICH) coordinator 187˙419.00

Map

 Project objective

More than one billion people worldwide (165 million in Europe) suffer from diseases of the central nervous system (CNS). With Europe's aging societies, the European Commission identified brain research as one of the key research areas under healthcare (https://ec.europa.eu/research/health/). Many neurodegenerative diseases are still without cure (e.g., Parkinson’s, amyotrophic lateral sclerosis (ALS) and Alzheimer’s) and repeated failures in clinical trials increase the demand for novel screening technologies to be implemented in the early phases of drug discovery.

Recent studies show that synaptic dysfunction is involved in CNS diseases. New technologies for neuronal screening targeting synaptic and network activity, combined with disease model cells in vitro, will enable novel functional assays for CNS drug discovery. This project aims to develop MAPSYNE, a Miniaturized Automated Patch-clamp SYstem combined with high-density microelectrode arrays (HD-MEAs) for multi-scale functional mapping of NEuronal networks. Patch-clamp allows detection of synaptic events and action potentials (APs) of single cells, while HD-MEAs record APs of thousands of neurons in parallel (also track APs propagating along axons). Combining the two methods will allow access to neuronal electrical signals across spatial and temporal scales.

MAPSYNE's main objectives are (1) the development of hardware and software for a fully automated mini-patching system on HD-MEAs and (2) proof-of-concept experiments using primary and human induced pluripotent stem cell (h-iPSC)-derived neuronal networks.

MAPSYNE will be designed for long-term, label-free recording of cell cultures. Other applications include local application of drugs (e.g, synaptic blockers on neuronal compartments). After this project, the ER envisions the commercialization of MAPSYNE, and eventually, its usage for preclinical CNS drug discovery.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAPSYNE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAPSYNE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

DISMAC-Y (2019)

State disintegration in the context of macroeconomic crisis - the case of Yugoslavia

Read More  

MTrill (2019)

Machine Translation Impact on Language Learning

Read More  

CIGNUS (2019)

CuInGaSe Nanowires Under the Sun

Read More